FIELD: pharmacology.
SUBSTANCE: composition contains an effective amount of combination of soluble part of a whole-cell preparation Mycoplasma hyopneumoniae (M. hyo); protein antigen ORF2 of pig circovirus of type 2 (PCV2) and antigen of genetically modified live virus of pig reproductive and respiratory syndrome (PRRS), where the soluble part of the whole-cell preparation contains M. hyo-specific soluble protein antigens and is separated from the insoluble cell bulk and, in essence, is free from both (i) Ig (G), and (ii) of immunocomplexes, consisting of Antigen attached to immunoglobulin.
EFFECT: induction of an immune response in a subject against a disease caused by M hyo, PCV2 and PRRS.
21 cl, 13 dwg, 21 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
| MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
| INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
| PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| Mycoplasma hyopneumoniae AVIRULENT ADJUVANT LIVE VACCINE | 2008 |
|
RU2489164C9 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| VACCINE FOR PROTECTION AGAINST LAWSONIAINTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRUS | 2009 |
|
RU2496520C2 |
| METHOD FOR PREPARING A READY-TO-USE COMBINED PCV2 / MYCOPLASMA HYOPNEUMONIAE VACCINE | 2015 |
|
RU2731845C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
